A settlement was reached with the defendants in the lawsuit filed on behalf of certain investors of Altair Nanotechnologies Inc (OTC: ALTI) over alleged securities laws violations and a deadline to submit the settlement claim is upcoming on May 30, 2016 and OTC: ALTI investors should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 05/12/2016 --The Shareholders Foundation announced that a deadline is coming up on May 30, 2016 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased shares of Altair Nanotechnologies Inc (OTC: ALTI) between May 15, 2013 and September 25, 2014.

Investors who purchased a significant amount of shares of Altair Nanotechnologies Inc (OTC: ALTI) between May 15, 2013 and September 25, 2014, have certain options and should contact the Shareholders Foundation by email at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The settlement proof of claim form or detailed settlement notice for the settlement in the Altair Nanotechnologies Inc (OTC: ALTI) Investor Securities Class Action Lawsuit can be downloaded at: http://shareholdersfoundation.com/case/altair-nanotechnologies-inc-otc-alti-investor-securities-class-action-lawsuit-09262014

In order to submit a claim an investor has to submit the claim proof to the class action claim administrator in a timely manner. The deadline to submit the proof with the class administrator is May 30, 2016. The class action administrator for this case is Strategic Claims Services.

The lawsuit was originally filed in the U.S. District Court for the Southern District of New York against Altair Nanotechnologies Inc over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements made between May 15, 2013 and September 4, 2014. According to the complaint the plaintiff alleges on behalf of purchasers of Altair Nanotechnologies Inc (OTC: ALTI) common shares between May 15, 2013 and September 4, 2014, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that Defendants made allegedly false and/or misleading statements and/or allegedly failed to disclose that Altair Nanotechnologies, Inc was experiencing significant executive management and accounting level turnover in 2013 which led to a lack of segregation of duties throughout the Company and resulted in a lack of controls to perform a timely review of transactions at an appropriate level of precision, that Altair Nanotechnologies, Inc did not implement adequate procedures and controls over the 2013 year-end financial close and reporting process to ensure timely filings in compliance with its financial reporting requirements, that Altair Nanotechnologies, Inc did not implement adequate procedures and controls to appropriately evaluate routine and non-routine transactions, and as a result, did not detect the material misstatements that were identified by its auditor during its audit process, that Altair Nanotechnologies, Inc did not implement adequate procedures and controls to ensure accurate and timely communication with its subsidiaries in China, and that as a result of the foregoing Altair Nanotechnologies, Inc did not implement adequate procedures and controls to ensure the completeness and accuracy of its consolidated financial statements and related subsequent events.

Those who purchased shares of Altair Nanotechnologies Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com